Contineum Therapeutics, Inc. financial data

Symbol
CTNM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3565 General Atomics Court, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.21K %
Debt-to-equity 7.72 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19M shares
Common Stock, Shares, Outstanding 2.38M shares
Common Stock, Value, Issued 2K USD
Weighted Average Number of Shares Outstanding, Basic 25.7M shares +1007%
Weighted Average Number of Shares Outstanding, Diluted 25.7M shares +1007%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 9.73M USD +49.7%
General and Administrative Expense 3.25M USD +107%
Operating Income (Loss) -13M USD -60.8%
Nonoperating Income (Expense) 2.71M USD +59.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.3M USD -61.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.3M USD -64.2%
Earnings Per Share, Basic -0.4 USD/shares +85.1%
Earnings Per Share, Diluted -0.4 USD/shares +85.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.9M USD
Marketable Securities, Current 173M USD
Cash, Cash Equivalents, and Short-term Investments 214M USD
Assets, Current 215M USD
Property, Plant and Equipment, Net 888K USD
Operating Lease, Right-of-Use Asset 0 USD
Other Assets, Noncurrent 3K USD
Assets 216M USD
Accounts Payable, Current 1.4M USD
Employee-related Liabilities, Current 2.18M USD
Accrued Liabilities, Current 3.8M USD
Liabilities, Current 5.81M USD
Operating Lease, Liability, Noncurrent 0 USD
Other Liabilities, Noncurrent 0 USD
Liabilities 5.81M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 561K USD
Retained Earnings (Accumulated Deficit) -103M USD
Stockholders' Equity Attributable to Parent 210M USD
Liabilities and Equity 216M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.98M USD -52.1%
Net Cash Provided by (Used in) Financing Activities -18K USD +97.1%
Net Cash Provided by (Used in) Investing Activities 8.73M USD -6.67%
Common Stock, Shares Authorized 39.6M shares 0%
Common Stock, Shares, Issued 2.38M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 738K USD -78.9%
Payments to Acquire Property, Plant, and Equipment 147K USD +183%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.58M USD -52.7%
Operating Lease, Liability, Current 611K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 312M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 61K USD -16.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares